Life
FDA investigates tumor risk after Zolgensma gene therapy
The agency recommends monitoring patients who received Zolgensma or Itvisma while it reviews whether to take regulatory action.
November 8, 2026 · 2 min read
THE AMERICAN EDIT
Gene therapy
The latest reporting, guides and features on Gene therapy.